Ayesha Abdulkadar Iqbal is a Decatur, Georgia based female rheumatologist who is specialized in Rheumatology. Active license number of Ayesha Abdulkadar Iqbal for Rheumatology is 056297 in Georgia. Ayesha Abdulkadar Iqbal treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Ayesha Abdulkadar Iqbal speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
1670 Clairmont Rd, Dept. Of Rheumatology 111, Decatur, Georgia, 30033-4004
Phone:
404-321-6111
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1710921556
NPI Enumeration Date:
15 Jun, 2006
NPI Last Update On:
03 Nov, 2015
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ayesha Abdulkadar Iqbal are as mentioned below.
License Number
Specialization
State
Status
056297
Rheumatologist
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1670 Clairmont Rd, Decatur, Georgia
Zip:
30033-4004
Phone Number:
404-321-6111
Fax Number:
--
Patients can reach Ayesha Abdulkadar Iqbal at 1670 Clairmont Rd, Dept. Of Rheumatology 111, Decatur, Georgia or can call to book an appointment on 404-321-6111. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.